增加吸入粉雾剂肺部沉积率的方法研究进展
作者：贺建东;付廷明;郭立玮;
Author：
收稿日期： 年卷（期）页码：2008,(05):-585-587
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：肺部给药;空气动力学粒径;表面性质;载体;细粉分布比例
Key words：
基金项目：教育部博士点基金(批准号:2006315007);;
江苏省教育厅自然科学基金(05KJD360155)
中文摘要
肺部给药具有很多传统给药方式所无法比拟的优点,近年来发展非常迅速,但同时生物利用度低也成为限制其发展的主要因素。特综述空气动力学粒径、表面性质、载体等影响生物利用度的因素对肺部给药积率的影响。
参考文献
[1]Vermehren,Frokjaer,Aurstad,et al.Lung surfactant as a drugdelivery system[J].Inter J Pharmac,2006,37(8):89-92.
[2]Rita Vanbever.Performance-driven,pulmonary delivery of sys-temically acting drugs[J].Drug Delivery Today:Technologies,2005,1(2):39-46.
[3]Melnik RVN,David R,Jenkins.On computational control of flowin airblast atomisers for pulmonary drug delivery[J].Inter JPharmac,2006,239(1):23-25.
[4]Newman SP,Hollingworth A,Clark AR,et al.Effect of differentmodes of inhalation on drug delivery from a dry powder inhaler[J].Inter J Pharmac,1994,102(2):127-132.
[5]Kleinstreuer C,Zhang Z,Donohue JF,et al.Comparison ofmicro-and nano-size particle depositions in a human upperairway model[J].Aerosol Sci,2005,36(8):211-230.
[6]Hartwig Steckel,Heike G.Brandes.A novel spray-drying tech-nique to produce low density particles for pulmonary delivery[J].Inter J of Pharmac,2004,278(5):187-195.
[7]史宁,吴久鸿.干粉吸入剂的研究进展[J].中国新药杂志,2007,16(12):922-925.
[8]Kazuhiko Ikegamia,Yoshiaki Kawashimab,Hirofumi Takeuchib,et al.A newagglomerated KSR-592 b-form crystal system fordry powder inhalation formulation to improve inhalation perform-ance in vitro andin vivo[J].J Contr Rel,2003,88(11):23-33.
[9]Nora YK,Chew,Hak-Kim Chan.Use of solid corrugated parti-cles to Enhance powder Aerosol performance[J].Pharma Res,2001,18(8):1570-1577.
[10]甘莉,朱家壁.干粉吸入剂中粉末特性及其评价[J].国外医学药学分册,2003,30(1):51-55.
[11]Cassidy OE,Carter PA,Rowley G,et al.Triboelectrification ofspray-dried lactose prepared from different feedstock concentra-tions[J].J Pharm Pharmacol,2000,52(1):13-17.
[12]Martin,Anthony.Dry power inhaler formulation[J].Amer J Re-spiratory Critical Care Med,2005,50(9):1209-1227.
[13]Kyrre Thalberg,David Lindholm1,Anders Axelsson.Compari-son of different flowability tests for powders for inhalationpower[J].Technology,2004:146(8):206-313.
[14]金方,施丽西,陆敏,等.吸入剂有效部位药物沉降量试验方法的研究[J].中国药学杂志,1999,34(10):672-674.
[15]IrngartingeraV,Camugliaa,Dammb J,et al.Pulmonary delivery oftherapeutic peptides via dry powder inhalation:effects of mi-cronisation and manufacturing[J].Eur J Pharmac Biopharmac,2004,58(5):7-14.
[16]Cynthia Bosquillon,Catherine Lombry,Ve′ronique preat.Influ-ence of formulation excipients and physical characteristics of in-halation dry powders on their aerosolization performance[J].JContro Rele,2001,70(11):329-339.
[17]Boer,Hagedoorn,Gjaltema,et al.Air classifier technology(ACT)in dry powder inhalation[J].Inter J Pharmac,2006,310(11):72-80.
[18]Harting Steckel,Bernd W.Muller.In vitroevaluation of dry powerinhalerⅡ:influence of carrier particle size and concentration onin vitro deposition[J].Inter J Pharmac,1997,154(4):31-37.
[19]Tejas R Desai,Dongqing Li,Warren H Finlay,et al.Determina-tion of surface free energy of interactive dry powder liposome for-mulations using capillary penetration technique[J].Colloids Sur-faces B:Biointerfaces,2001,22(11):107-113.
【关闭】
